Brackmann S A, Gerritzen A, Oldenburg J, Brackmann H H, Schneweis K E
Institute of Medical Microbiology and Immunology, University of Bonn, Germany.
Blood. 1993 Feb 15;81(4):1077-82.
This study was performed to determine the risk of family members of anti-hepatitis C virus (HCV)-positive hemophilia patients (index patients) for infection with HCV compared with the risk of acquiring hepatitis B virus (HBV), human immunodeficiency virus (HIV), and hepatitis A virus (HAV) infection. All index patients (n = 141) were found to be positive by first and second generation anti-HCV enzyme immunoassays (EIAs). Among their household contacts (n = 228), 224 were negative and 1 positive by both assays. Three contacts gave positive results in first generation anti-HCV EIA and negative results in second generation assay. This latter result was confirmed by further tests (neutralization test, synthetic peptides, and supplemental assay). Percent positivity for anti-HBc was about the same in non-sexual household contacts and sexual partners (13 of 109 [12%] and 7 of 54 [13%], respectively). Percent prevalence of anti-HBc was higher in contacts of index patients with chronic hepatitis B than in those of index patients who had recovered from that disease (6 of 20 [30%] and 14 of 133 [10%], respectively; P < .05). The HBV infection rate of contacts participating in controlled self-treatment was not higher than that of controls (3 of 57 [5%] and 10 of 98 [10%], respectively). Of 44 sexual partners, 5 (11%) were found to be positive for anti-HIV. Prevalence of anti-HAV matched with the age-related distribution in the German population. These findings suggest that intrafamilial transmission of HCV to family members of hemophilia patients is uncommon. In contacts of hemophilia patients, the risk of acquiring HBV infection seems to be as high in household contacts as in sexual contacts. Participation in controlled self-treatment does not appear to be an additional risk for HCV and HBV infection. There is no doubt that sexual transmission of HCV is less common than that of HBV and HIV.
本研究旨在确定丙型肝炎病毒(HCV)阳性血友病患者(索引患者)的家庭成员感染HCV的风险,并与感染乙型肝炎病毒(HBV)、人类免疫缺陷病毒(HIV)和甲型肝炎病毒(HAV)的风险进行比较。所有索引患者(n = 141)通过第一代和第二代抗HCV酶免疫测定(EIA)检测均呈阳性。在他们的家庭接触者(n = 228)中,224人两种检测均为阴性,1人两种检测均为阳性。3名接触者第一代抗HCV EIA检测结果为阳性,第二代检测结果为阴性。后一结果通过进一步检测(中和试验、合成肽和补充检测)得到证实。抗HBc阳性率在非性接触的家庭接触者和性伴侣中大致相同(分别为109人中的13人[12%]和54人中的7人[13%])。慢性乙型肝炎索引患者的接触者中抗HBc的流行率高于已从该病康复的索引患者的接触者(分别为20人中的6人[30%]和133人中的14人[10%];P <.05)。参与对照自我治疗的接触者的HBV感染率不高于对照组(分别为57人中的3人[5%]和98人中的10人[10%])。在44名性伴侣中,5人(11%)抗HIV检测呈阳性。抗HAV的流行率与德国人群中按年龄分布的情况相符。这些发现表明,HCV在血友病患者家庭成员中的家庭内传播并不常见。在血友病患者的接触者中,家庭接触者感染HBV的风险似乎与性接触者一样高。参与对照自我治疗似乎不会增加感染HCV和HBV的风险。毫无疑问,HCV的性传播比HBV和HIV的性传播少见。